ロード中...
Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy
Nilotinib, a tyrosine kinase inhibitor, has been studied extensively in various tumor models; however, no information exists about the pharmacological action of nilotinib in bacterial infections. Mycobacterium bovis (M. bovis) and Mycobacterium avium subspecies paratuberculosis (MAP) are the etiolog...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562972/ https://ncbi.nlm.nih.gov/pubmed/31130711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8050506 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|